The timeline for the key clinical trial data readout of Annovis Bio Inc. has been clarified.

老虎证券2026/07/07 11:23

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Regarding data on symptom improvement efficacy, results are expected to be revealed in the first quarter of 2027. More importantly, data aimed at evaluating whether the drug can alter the progression of the disease are planned to be released in the first quarter of 2028. This timeline provides investors interested in the company with clear research progress milestones.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The timeline for the key clinical trial data readout of Annovis Bio Inc. has been clarified.

You may also like

Crypto prices